Optimising patient safety
Professor Parisa Aslani has dedicated her career to improving the quality use of medicines through better consumer information and adherence. She was conferred as...
NDSS changes to assist in diabetes management
Changes to the Australian Government’s National Diabetes Services Scheme (NDSS) took effect on 1 December, altering the range and price of certain products available...
Q&A: Safescript
I want to implement SafeScript in my pharmacy. What do I do, and how long does the process take?
SafeScript is an initiative by the...
What transpired at the inaugural GP-Pharmacists Symposium?
PSA's inaugural GP Pharmacists Symposium underscored the expanding scope of the profession – and the policy gaps that still need closing.
Medicinal cannabis: Patient access and clinical evidence
In the August 2017 edition of Australian Pharmacist (page 10), I provided background on the regulatory scheme for cultivation and manufacture of medicinal cannabis,...
Opioid therapy challenges in rural Australia
For more than a decade, healthcare workers in rural and remote areas have been aware of the rising incidence of non-prescribed opioid medicines use....